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Histone H3 K4 methylation regulates the Spindle Assembly Checkpoint through 
direct binding of multiple checkpoint components and Cdc20 
 
Andria Schibler, Ph.D. Candidate 
Supervisory Professor: Sharon Dent, Ph.D. 
 
Histone H3K4 methylation is conserved across species and is associated with active 
transcription. By using Saccharomyces cerevisiae, we found histone H3K4 methylation 
has a previously unknown role in regulating mitosis through the Spindle Assembly 
Checkpoint. The Spindle Assembly Checkpoint ensures duplicated chromosomes are 
segregated correctly and each daughter cell receives one full copy of the genome. Our 
data show SET1 mutants and histone H3K4 mutants display a resistance to the mitotic 
poison, benomyl. Moreover methylated histone H3 directly binds to Spindle Assembly 
Checkpoint proteins Bub3 and Mad2 as well as the activator of the Anaphase 
Promoting Complex (APC) protein Cdc20. MAD2 encodes a HORMA domain, which I 
identify as a novel histone binding motif. Mad2 maintains two differing conformations, 
closed Mad2 (C-Mad2) and open Mad2 (O-Mad2). We find C-Mad2 increases the 
Mad2-H3 interaction. In addition, O-Mad2 limits the H3-Mad2 interaction. Further 
analysis, shows C-Mad2 can bind to all unmodified, mono-, di-, and tri-methylated 
H3K4 while O-Mad2 loses H3 binding ability when H3K4 is di- or tri-methylated. Here 
we show H3K4 methylation inhibits the Spindle Assembly Checkpoint from correctly 
deactivating after cell cycle arrest by binding C-Mad2. 
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Chapter 1: Introduction 
 
Chromatin during DNA Replication, Transcription and Repair 
The eukaryotic genome is made up DNA, which is wrapped around histone proteins to 
form nucleosomes. Each canonical nucleosome contains two copies of histone H2A, 
H2B, H3 and H4 and 146 bp of DNA. Multiple nucleosomes further condense into 
chromatin fibers in a highly ordered manner, which constitute chromosomes. Although 
the genome is tightly wrapped around nucleosomes, genomic DNA must be accessible 
for cellular functions such as DNA replication, transcription, and DNA repair. 
 
Replication 
Before division can occur, cells must first duplicate each chromosome. Saccharomyces 
cerevisiae is used as a model to better understand the DNA elements and proteins 
required for DNA replication.  By using genetic screens in S. cerevisiae, it was found 
DNA synthesis requires Autonomously Replicating Sequence (ARS) elements, which 
recruit proteins essential for DNA replication. The ARS is the location at which multiple 
proteins associate and form the pre-replication complex (pre-RC) in a stepwise fashion. 
First, the Origin Recognition Complex (ORC) identifies and binds the ARS Consensus 
Sequence (ACS) and recruits Cdc6 and Cdt1. The ORC, Cdc6 and Cdt1 subsequently 
recruit the MCM (Mini Chromosome Maintenance) complex. Once all of these 
components are assembled replication can begin and chromosomes can be duplicated.  
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Nucleosome occupancy must be highly coordinated to concur with DNA replication. For 
replication to take place, the ACS must be free from nucleosomes to promote ORC 
recognition and binding (Simpson, 1990). Nucleosomes must be limited, removed, or 
repositioned from the ACS to create the nucleosome free region (NFR). Surprisingly, 
nucleosomes proximal to the ACS are required for the pre-RC formation (Lipford and 
Bell, 2001), implicating nucleosome positioning as an intricate regulatory step 
necessary for proper DNA replication. Before new genomic DNA can be polymerized, 
nucleosomes must be removed and after DNA synthesis, histone octamers must be 
deposited and reassembled onto DNA creating two sister chromatids. This temporal 
and spatial regulation process is coordinated by linking the MCM complex with histone 
chaperone proteins with a physical association between DNA duplication machinery 
and proteins able to remove and reassemble nucleosomes (Groth et al., 2007).  
 
Transcription 
Comparable to how DNA polymerases need NFRs to function during replication, RNA 
polymerases also require access to DNA during transcription. Therefore, transcription 
is a DNA-based cellular process, which is either inhibited or promoted through 
nucleosome positioning and remodeling. The gene promoter, a region upstream of the 
gene body, that dictates where RNA polymerase will bind, thereby defining the 
transcription start site (TSS), is critical to facilitate transcription. Gene promoters and 
sequence specific binding sites for transcription factors correlate with NFRs (Bernstein 
et al., 2004; Lee et al., 2007b; Yuan et al., 2005) allowing access to the genome. In 
	   3	  
addition, NFRs are associated with the region past the gene body after the transcription 
termination site (TTS) (Mavrich et al., 2008). Lastly, throughout the gene body, there is 
a high occupancy of nucleosomes, suggesting the gene regulatory regions are 
accessible and the coding regions are protected. This allows for regulatory proteins to 
bind and recruit transcriptional elements, although the nucleosomes must be moved or 
evicted prior to RNA synthesis and reassembled or replaced after the gene body has 
been transcribed into mRNA. Regulatory complexes such as ATP-dependent chromatin 
remodelers and the regulation of histone occupancy by transcription factors is one way 
of controlling the access to DNA for mRNA generation. For example, loss of function 
mutations of the DNA binding proteins that promote transcription, such as Abf1, Reb1, 
and Rap1, showed an increase in nucleosome occupancy suggesting active 
transcription can also affect nucleosome positioning and DNA accessibility (Badis et al., 
2008; Ganapathi et al., 2011).  
 
In addition, ATP dependent chromatin remodelers can either evict or move 
nucleosomes. Two well studied chromatin remodeling complexes that were found to 
remove nucleosomes and regulate transcription are the SWI/SNF complex and the 
RSC complex. The SWI/SNF complex was shown to remove nucleosomes and this 
eviction subsequently regulates transcription (Hirschhorn et al., 1992; Matallana et al., 
1992).  Unlike the SWI/SNF complex, which is exclusively recruited to RNA PolII 
genes, another chromatin remodeling complex was shown to regulate both RNA PolII 
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and PolIII transcription. The RSC complex was shown to remodel chromatin as well as 
regulate transcription (Cairns et al., 1996).  
 
DNA Repair 
DNA damage must be repaired to maintain genomic integrity and support cell survival. 
Exposure to UV radiation induces DNA lesions, which must be identified and remedied 
through nucleotide excision repair (NER). Although most UV lesions take place within 
DNA wrapped around the histone octamer (Gale et al., 1987), the nucleosome must be 
removed or evicted prior to DNA damage repair. Previous studies reported 
nucleosomal remodeling after UV induced DNA damage and repair (Smerdon and 
Lieberman, 1978) indicating a cellular response to reposition nucleosomes and 
facilitate access to the damaged DNA. Further studies identified Rad4 and Rad23 as 
proteins required for the identification of DNA lesions (Jansen et al., 1998) and 
additional research found the SWI/SNF chromatin remodeling complex induced 
nucleosomal changes upon UV damage (Yu et al., 2005). Lastly, it has been reported 
that subunits of the SWI/SNF complex purify with Rad4 and this interaction was 
enhanced upon UV irradiation treatment, linking the identification of DNA lesions with 
the recruitment of chromatin remodeling complexes to facilitate NER (Gong et al., 
2006).  
 
Double strand breaks are an additional deleterious DNA damaging event and can be 
repaired by two differing pathways homologous recombination (HR) and 
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nonhomologous end-joining (NHEJ).  NHEJ requires Ku70 and Ku80, which bind to 
DNA and the DNA ligase IV factors Lif1 and Nje1 in combination with the catalytic 
subunit Dnl4 to properly repair DSBs (Varambally et al., 2005). HR requires Rad50, 
Mre11, and Xrs2 proteins, which compose the Mre11 complex. The Mre11 complex 
can bind to DNA and exhibits exonuclease activity (Chen et al., 2001; Paull and Gellert, 
1998) required for DSB repair through HR. Interestingly, chromatin remodeling 
complexes have also been implicated in DSB repair. Both INO80 and the SWI/SNF 
complexes have been localized to sites of DSBs by chromatin immunoprecipitation 
(ChIP) experiments and mutations to these complexes result in a sensitivity to DNA 
damaging agents (Chai et al., 2005; van Attikum et al., 2004). The INO80 complex was 
later shown to remove histones from sites of DSBs and disruption of this event resulted 
in a loss of efficient binding of the Mre11 complex (van Attikum et al., 2007) indicating a 
requirement for nucleosome remodeling prior to DSB repair.  
 
Histones and Histone modifications 
In addition to nucleosome remodeling, chromatin is regulated through post-translational 
modifications (PTMs). Histone proteins contain an unstructured N-terminal tail that 
protrudes from the “core” portion of the nucleosome (Luger et al., 1997). Histone tails 
are subjected to covalent PTMs such as acetylation, phosphorylation, ubiquitination, 
and methylation among others (Strahl and Allis, 2000). Histone modifications are 
known to alter chromatin structure and selectively recruit or exclude protein complexes 
and other histone modifying enzymes to histones thus regulating many cellular 
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processes such as DNA damage (Sollier et al., 2004), transcription (Santos-Rosa et al., 
2002), and telomere maintenance (Krogan et al., 2002). Histone modifications are 
found on all histones, including the canonical histones, H2A, H2B, H3, and H4. Lastly, 
histone modifications and their downstream functions are highly conserved from yeast 
to human.  
 
In addition to the nucleosome remodeling required for proper DNA replication and 
repair, PTMs of histone tails are also implicated in regulating these processes. A 
number of mutations affecting histone PTMs result in inefficient DNA replication 
suggesting loss of specific histone modifications affect DNA duplication. Histone 
modifications such as H3 and H4 acetylation, H3K36 methylation, and H3K4 
methylation (Pryde et al., 2009; Rizzardi et al., 2012; Unnikrishnan et al., 2010) 
Lastly, mutants inhibiting specific PTMs of histone tails, such as H2A phosphorylation, 
H2B ubiquitination, H3K79 methylation as well as multiple actetylation events on H3 
and H4 are sensitive to ionizing radiation exposure, which is a DNA damaging agent 
resulting in DSBs (reviewed in (Li, 2012). 
 
PTMs of histones have been extensively studied during transcription with specific 
histone modifications concurring with transcription activation, while other histone 
modifications are associated with a silenced or inactive chromatin status. Histone 
acetylation has been largely studied as an active transcriptional mark because this 
modification can interrupt the association of the histone octamer with DNA. Gcn5 is a 
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well-studied histone acetyltransferase with activity towards lysines on H2B, H3, and H4 
(Suka et al., 2001; Winkler et al., 2002). Although, histone methylation can take place 
on both arginines and lysines, lysine methylation of Histone H3K4 and K36 are 
associated with active transcription in yeast (Bernstein et al., 2002; Rao et al., 2005).  
 
Histone H3 Methylation 
In yeast, histone H3 K4, K36, and K79 can be mono-, di-, or tri-methylated (Garcia et 
al., 2007) and these methylation events have specific roles and are positioned 
precisely. In particular, Histone H3K4 trimethylation localizes to gene promoters and is 
associated with active transcription. In addition, H3K4 dimethylation is located 
throughout the gene body of both repressed and active genes (Bernstein et al., 2002; 
Santos-Rosa et al., 2002).  Histone H3K4 methylation has been extensively studied in 
multiple organisms. Histone H3K4 methylation is associated with active transcription in 
yeast and this is conserved in mammals (Bernstein et al., 2002) (Krogan et al., 2003). 
In addition, H3K4 methylation is enriched at replication origins and loss of H3K4 
dimethylation affects replication efficiency (Rizzardi et al., 2012). Unlike humans, which 
maintain multiple H3K4 methyltransferases, such as SET1A, SET1B, MLL1, MLL2, 
MLL3 and MLL4, yeast Set1 is responsible for all H3K4 methylation events (Shilatifard, 
2012). Removing or inhibiting SET1 in yeast results in a loss of all detectable histone 
H3K4 methylation events.  
 
The enzymes required for each lysine methyltransferase event on histone H3 has been 
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identified. The lysine methyltransferase responsible for H3K36 methylation is Set2 and 
the protein that methylates histone H3K79 is Dot1. Lastly the H3K4 methyltransferase 
is Set1. Set1 resides inside a multiprotein complex termed COMPASS. The COMPASS 
complex is well-studied and exhibits lysine methyltransferase activity when Set1, the 
catalytic subunit is included. Once incorporated into COMPASS, Set1 can mono-, di-, 
and tri-methylated histone H3K4. In yeast, multiple components of COMPASS have 
been identified through biochemical purification, including Swd1, Swd2, Swd3, Spp1, 
Bre2, Set1, Sdc1, and Shg1 (Figure 1) (Miller et al., 2001).  
 
Yeast Set1 is a conserved protein with homology to human MLL1. In humans, 
translocations of MLL1 are associated with leukemogenesis (Zeleznik-Le et al., 1994) 
and correlates with a poor prognosis (Pui et al., 1994). Interestingly, the Set1 complex 
and the MLL complex maintain strikingly similar features. Set1 requires incorporation 
into COMPASS for lysine methylation activity, while MLL is also incorporated into a 
COMPASS-like complex. Presently, little is known about how mutating MLL1 
contributes to leukemogenesis. Selecting known cellular functions regulated by SET1 in 
yeast will identify unknown pathways regulated by MLL1 in humans.  
 
Regulation of H3K4 methylation 
H3K4 methylation is highly regulated. Multiple cellular events are required for H3K4 
methylation. Previous research found H2B mono-ubiquitination is necessary for di- and 
trimethylation of histone H3K4 (Sun and Allis, 2002). In yeast, histone H2B is mono-
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ubiquitinated on lysine (K) 123 and this is conserved on K120 in vertebrates (Thorne et 
al., 1987). The E2 enzyme, Rad6, required for this modification has been identified 
(Robzyk et al., 2000). Later studies found Bre1, an E3 ligase, is also required (Wood et 
al., 2003) for H2B ubiquitination, and loss of either Rad6 or Bre1 abolishes detectable 
H3 K4 di- and trimethylation although H3K4 monomethylation is still present (Seol et 
al., 2006).  Additional studies identified H2B ubiquitination is also an upstream event for 
dimethylation and trimethylation of histone K79 but not mono-methylation of this lysine 
residue. Interestingly, although histone H3K4 and K79 methylation are events 
associated with active transcription, another active mark, histone H3K36 methylation, 
was not affected (Dehe et al., 2005; Shahbazian et al., 2005). 
 
Methyl Reading Domains  
A main function of histone H3 methylation is to either promote or inhibit protein-protein 
interactions. Fitting with this model, a number of lysine methyl binding motifs have been 
identified. One example is the WD40 domain, which was shown to read differing H3K4 
methylation states (Wysocka et al., 2005). An additional protein with the ability to read 
H3K4me2 is PHF20, which contains a Tudor domain (Kim et al., 2006). Also, proteins 
containing PHD fingers were identified as methyl readers. More specifically the PHD 
finger of ING2 was shown to preferentially bind H3K4me3 (Shi et al., 2006). Lastly, 
chromo, MBT, and PWWP domains have been shown to selectively interact with 
distinct H3 methylation events (Bannister et al., 2001; Kim et al., 2006; Wang et al., 
2009). 
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Figure 1: The COMPASS Complex 
An illustration of the multi-protein complex termed COMPASS. COMPASS is composed 
of multiple proteins including Swd1, Swd2, Swd3, Bre2, Sdc1, Spp1, Shg1, and the 
catalytic subunit, Set1. 
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Figure 1  
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Non-histone substrates of COMPASS  
In addition to methylation of histone H3, COMPASS can also dimethylate Dam1, which 
is a kinetochore protein associated with the DASH complex. In yeast, the DASH 
complex forms a ring around microtubules and localizes to the kinetochore during 
cellular division. Dam1 methylation events block Ipl1 mediated phosphorylation of 
surrounding serines (Zhang et al., 2005). The regulatory events required for Dam1 
methylation have bee identified. Like H3K4 methylation Dam1 methylation requires 
H2B ubiquitination, which shows changes in chromatin modifications can also affect the 
PTMs of non-histone proteins (Latham et al., 2011).  
 
 
Cell Division 
 
Cell division is a multi-step process that involves the partitioning of the newly duplicated 
genome into two daughter cells. Prior to mitosis the genome must be replicated which 
requires the removal of nucleosomes and repackaging of the sister chromatids into 
newly duplicated chromosomes. During mitosis, DNA must segregate evenly allowing 
for one complete copy of each genome to be maintained in each newly formed cell. S. 
cerevisiae divides the duplicated genome by connecting the mitotic spindle to each 
duplicated chromosome, or sister chromatid, in a bipolar fashion via the kinetochore. 
The kinetochore is a multi-protein complex associated with the centromeric region of 
each sister chromatid. These microtubule-kinetochore attachments allow for tension 
across the mitotic spindle from one spindle pole body to the other. The sister 
chromatids are then pulled away from each other to opposite sides of the cell before 
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the two nuclei segregate and the daughter cells divide. Ipl1 is the sole Aurora kinase in 
yeast and regulates many mitotic functions during cellular division. Ipl1 mediated 
phosphorylation events regulate microtubule-kinetochore interactions and mitotic 
spindle disassembly (Biggins et al., 1999; Buvelot et al., 2003).  
 
The Spindle Assembly Checkpoint 
To guard against aberrant chromosome segregation during cell division, eukaryotes 
maintain the Spindle Assembly Checkpoint (SAC), which acts as a surveillance 
mechanism to identify defects in tension (Li and Nicklas, 1995) or mitotic spindle- 
kinetochore attachments (Rieder et al., 1994). Thus, the SAC pathway ensures each 
cell maintains one complete copy of the genome. 
 
If improper microtubule-kinetochore attachments or lack of tension across the mitotic 
spindle arise during mitosis, Ipl1 phosphorylates a number of kinetochore proteins 
which activate the SAC preventing the cell from entering anaphase until these defects 
are remedied (Biggins and Murray, 2001). Loss of SAC function results in aneuploidy, a 
hallmark of cancer, therefore the SAC is essential for maintaining genomic integrity.  
Previous studies used S. cerevisiae as a model to identify components of the SAC 
such as MAD1 (Mitotic Arrest Defect 1), MAD2, MAD3 (Li and Murray, 1991) BUB1 
(Budding Uninhibited by Benomyl 1) and BUB3 (Hoyt et al., 1991) among others. 
Mutations in these genes prevent activation of the SAC, resulting in aneuploidy. These 
mutants are also sensitive to mitotic poisons that stress the cell during mitosis, such as 
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benomyl and nocodazole. Benomyl and nocodazole destabilize mitotic spindle 
microtubules thereby interrupting proper mitotic spindle-kinetochore interactions 
creating a loss of tension. Stressing mutant cells with mitotic poisons antagonizes 
mitotic spindle polymerization and chromosome attachments causing the Spindle 
Assembly Checkpoint to be engaged and evaluated. In mutants defective in SAC 
activation, chromosomes divide without a surveillance mechanism to assess proper 
mitotic spindle-kinetochore attachments and tension, thereby subjecting cells to an 
increased risk of aneuploidy and eventual cell death.  
 
By using genetic and molecular techniques the SAC has been extensively studied. 
Previous research found that the SAC is spatially and temporally regulated. Until SAC 
activation, Mad1 and Mad2 localize to the nuclear pore complex (Iouk et al., 2002). 
Bub1 and Bub3 bind to kinetochores in early mitosis regardless of a mitotic 
disturbance. In contrast, Mad1 and Mad2 localize to the kinetochore only following SAC 
activation (Gillett et al., 2004). SAC components not only localize to the kinetochore for 
mitotic regulation, SAC proteins bind to and inhibit Cdc20. Cdc20 is a component of the 
Anaphase Promoting Complex (APC) and Cdc20 is thought to recruit proteins to the 
APC for ubiquitination and subsequent protein degradation. SAC inhibition of the APC 
through Cdc20 is due to Bub3, Mad2, and Mad3 directly binding Cdc20 (Figure 2), 
which causes APC inhibition, decreased proteolysis, and increased stability of a 
number of APC substrates such as Pds1 (Securin), Ase1, and Clb2.  
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After SAC activation, Mad2 binds to Cdc20 and adopts a specific active closed Mad2 
(C-Mad2) conformation, while free Mad2 remains in an inactive open Mad2 (O-Mad2) 
conformation (Luo et al., 2000; Nezi et al., 2006; Sironi et al., 2002). The C-Mad2-
Cdc20 complex is thought to create a template that converts O-Mad2 to C-Mad2 for 
further inhibition of Cdc20, thereby perpetuating SAC activation, cell cycle arrest, and 
APC inhibition. The formation of the O-Mad2-C-Mad2 dimer is required for proper SAC 
activation and mitotic arrest in yeast (Nezi et al., 2006). Although much is known about 
how the SAC is activated and maintained, few experiments show how the SAC is 
silenced. In vertebrates, p31comet was shown to be a negative regulator of the SAC (Xia 
et al., 2004). p31comet interacts directly with C-Mad2 but can not bind to O-Mad2. 
Moreover, binding of p31comet to C-Mad2 blocks C-Mad2-O-Mad2 dimerization, thereby 
preventing Cdc20 inhibition effectively silencing the SAC (Habu et al., 2002; Mapelli et 
al., 2006; Xia et al., 2004). 
Histone modifications are known to alter chromatin structure and selectively recruit or 
exclude protein complexes to histones thus regulating many cellular processes. In this 
study, we examined COMPASS and the role of histone H3 K4 methylation in regulating 
mitosis. Here we demonstrate that Set1, a lysine methyltransferase negatively 
regulates the SAC through methylation of histone H3K4.   
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Figure 2: An Illustration of APC inhibition by SAC proteins  
Cdc20 is an activator of the Anaphase Promoting Complex (APC) and Cdc20 recruits 
substrates to the APC for subsequent lysine ubiquitination and proteolysis (active). The 
SAC components Bub3, Mad2, and Mad3 bind to Cdc20 and inhibit the E3 ligase 
activity of the APC (inactive).  
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Figure 2  
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Aims and Rationale for This Study 
 
The cellular role of Ipl1 (Increase in Ploidy 1)  has been extensively studied, and 
previous research determined that Ipl1 functions in regulating mitosis through 
phosphorylation of a number of kinetochore substrates (Cheeseman et al., 2002). IPL1 
temperature sensitive mutants lose and gain chromosomes due to a decrease in 
phosphorylation in kinetochore components. Previous research determined that a 
catalytically inactive set1 mutant has the ability to suppress the temperature sensitivity 
phenotype of mutant IPL1, showing Set1 regulates mitotic processes through lysine 
methylation. In addition, IPL1 mutant temperature sensitivity could be rescued by 
limiting the methylation of a novel Set1 substrate and kinetochore protein, Dam1. 
These data show not only that Set1 has mitotic functions, that include methylation 
events that take place at the kinetochore (Zhang et al., 2005). These data and others 
show Set1 has the ability to regulate mitosis through lysine methylation of non-histone 
substrates. In this study, we further investigated how Set1 regulates mitosis through 
lysine methylation activity with the following specific aims: 
 
1) Define how Set1 regulates mitosis or mitotic checkpoints through lysine 
methylation of Set1 substrates. Previous lab members identified Set1 regulates 
mitosis through a novel Dam1 methylation event that takes place at the kinetochore. I 
will further define how lysine methylation regulates mitosis by using genetic mutants 
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that abolish total all methylation of Set1 substrates as well as mutants that abolish 
individual methylation events of Set1 substrates such as histone H3 and Dam1.  
 
 
2) Define cell cycle changes and molecular events associated with loss of Set1 
mediated lysine methylation. Molecular studies such as Chromatin 
Immunoprecipitation (ChIP) assays, confocal microscopy, and cell cycle arrest and 
release experiments have uncovered numerous cellular events regulated by Ipl1. 
Because Set1 is known to attenuate the function of Ipl1 through lysine methylation, we 
will use similar assays with wild-type and set1 mutant cells to assay cell cycle changes, 
protein localization, and cell cycle phenotypes in cells deficient for Set1 mediated lysine 
methylation. 
3) Identify binding partners that interact with methylated and unmethylated Set1 
substrates. A major function of lysine methylation is to regulate protein-protein 
interactions. Although many methyl-lysine dependent binding proteins involved in 
transcriptional regulation have been defined, none have been identified during mitosis. I 
will perform in vitro experiments with recombinant proteins, to identify novel histone H3 
or Dam1 binding events. In the future, I will compare this binding in both wild-type and 
set1 mutants in vivo. Identifying proteins that are recruited to or excluded by methylated 
lysines in response to cell cycle checkpoints or mitosis will elucidate the mechanism by 
which Set1 regulates cell division. 
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Chapter 2: Materials and Methods 
 
 
Yeast Strain Generation, Media, and Culture Conditions  
Strains were derived from the BY4741 background using standard techniques (Burke et 
al., 2000). All strains generated in this study are isogenic to the wild-type strain unless 
otherwise noted. Deletion strains were constructed by replacing endogenous genes 
with a one-step gene replacement strategy. Cells were transformed and placed onto 
selection media to isolate resistant colonies. Genomic DNA was isolated from individual 
colonies and proper integration was verified by PCR using one primer specific to the 
cassette and one primer downstream of the gene locus. Strains used in this study are 
listed in Table 1 and primers used to generate or genotype these strains are listed in 
Table 2. All strains were grown in YPD (Yeast Peptone Dextrose) complete media at 
300 C and collected at mid-log phase for analysis unless otherwise noted.  
 
Benomyl Resistance Assays 
Plates were prepared with the indicated amounts of benomyl, dissolved in dimethyl 
sulfoxide (DMSO). Wild-type and mutant strains were grown overnight in rich media 
and placed onto either control plates (YPD or YPD with DMSO) or YPD plates 
containing benomyl (10µg/mL, 20µg/mL, 30µg/mL, and 40µg/mL). Plates were placed 
for 2-3 days at 300 C unless stated otherwise.  
 
  
	   21	  
Cell cycle distribution analysis 
Asynchronous mid-log phase cells were pelleted and resuspended in 4% 
paraformladahyde for 30 minutes, washed 3 times with PBS, and mounted onto slides. 
Cells were visualized by taking DIC images. The budding index of wild-type and set1 
mutants were assessed by dividing cells into three categories; cells with no bud, cells 
with a small bud, and cells with a large bud. These categories correspond to G1, S, and 
G2/M, respectively.  
 
Flow cytometry 
5mL culture of mid-log phase cells were pelleted and resuspended in 3 mL of dH2O. 7 
mL of 95% ethanol was added to the culture and incubated overnight at 40 C. Cells 
were pelleted washed in 5mL sodium citrate (pH 7.4). Cells are pelleted again and 
resuspended in 1mL 50mM sodium citrate with 0.25 mg/mL RNAse, and incubated for 
1 hour at 500 C. Proteinase K is then added for a final concentration of 1mg/mL and 
incubated for an additional hour at 500 C. 1mL of sodium citrate containing 16mg/mL of 
propidium iodide was added for a final concentration of 8mg/mL and incubated for 30 
minutes before flow cytometry analysis. Data was collected on a BD LSRFortessa™ 
(Becton Dickinson, San Jose, CA) and analyzed using FlowJo 7.6 software. Protocol 
was courtesy of Stephen P. Bell and can be found at: 
http://web.mit.edu/flowcytometry/www/.   
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Light Microscopy, DIC Images, and Budding Index 
Yeast strains were pelleted and resuspended in 4% paraformladahyde for 30 minutes, 
washed 3 times with PBS, and imaged. DIC images were taken on a Nikon 80i upright 
microscope using a Plan Apo 60x/1.4 N.A. objective. The microscope is controlled by 
Nikon Elements AR software. DIC images were used to calculate a budding index for 
each strain and assess overall cellular morphology.  
 
Immunofluorescence  
Immunofluorescence experiments were performed according to standard techniques 
(Burke et al., 2000). To visualize the mitotic spindle and nuclei, we used an anti-tubulin 
antibody (Millipore, CBL270, 1:500) and DAPI (Molecular Probes, 1µM). Following 
staining procedures, images of wild-type and mutant yeast cells were acquired with a 
LSM510-Meta confocal microscope (Carl Zeiss, Germany) using a 100× 
PlanApochromat/1.4 N.A. objective. Images were processed using ImageJ software 
(NIH) and Adobe Photoshop.  
 
Recombinant Protein Generation and Purification 
Budding yeast SAC genes were cloned into a pGEX4T1 vector to generate a N-
terminally tagged GST fusion protein (a description of the plasmids generated can be 
found in Table 3). Mutations were generated by using the QuikChange XL kit 
(Stratagene) and sequenced.   Proteins were expressed in the Escherichia coli strain 
Rosetta 2 (Novagen) by the addition of 0.2mM IPTG at 14oC for 20 hours. After protein 
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expression, cells were collected and suspended in lysis buffer (50mM Tris pH 7.5, 
150mM NaCl, 0.05% NP-40, 1mM PMSF, protease inhibitors, and 0.5mg/mL of 
lysozyme solution). The cells were incubated for 45 minutes at 4oC and lysed using an 
EpiShear Probe Sonicator (Active Motif). Lysed cells were centrifuged and the 
supernatant was removed and incubated with Glutathione Sepharose 4B (GE). 
Recombinant GST fusion proteins were eluted by the addition of 15mg/mL of L-
Glutathione (Sigma) dissolved in 100mM Tris pH 8.0. Recombinant proteins were 
resolved on a 4-12% Bis Tris gel and analyzed with Colloidal staining.  
 
Calf Thymus Histone Binding Assays 
Calf thymus histone binding assays were preformed by incubating 50µg of calf thymus 
histones (Worthington) with 10µg of recombinant GST fusion proteins in buffer (50mM 
Tris pH 7.5, 1M NaCl, and 1% NP-40) overnight. GST fusion protein histone 
interactions were assessed by adding Glutathione Sepharose 4B (GE) beads for 1 
hour, washing 5 times in buffer then resuspended in 5xSDS sample buffer and run on a 
4-12% Tris-Bis polyacrylamide gel, which was then transferred to a nitrocellulose 
membrane followed by western blot analysis.  
 
MLA Histone Binding Assays 
Similar to the calf thymus histone binding assay, 2µg of recombinant GST fusion 
proteins were incubated with 1µg of full length recombinant histone H3 with either no 
methylation on K4 or Methylated Lysine Analogs (K4me1, K4me2, and K4me3) (Active 
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Motif) in buffer (50mM Tris pH 7.5, 1M NaCl, and 1%NP-40) overnight. Glutathione 
Sepharose 4B (GE) beads were added for 1 hour, washed five times with buffer and 
the beads were resuspended in 5xSDS sample buffer. Proteins were resolved on a gel 
and interactions were assessed by transferring the proteins to a nitrocellulose 
membrane and using western blot analysis.  
 
Chromatin Immunoprecipitation (ChIP) 
Cells were grown to A600 O.D. of 1. Formaldehyde was added to a final concentration of 
1%. Glycine was added to a final concentration of 125mM. Cell pellets were washed, 
collected, and resuspended in buffer (1M sorbitol, 50mM Tris-Cl pH 7.4, 10mM β-ME, 
and Zymolase®). Spheroplasts were collected and resuspended in buffer (50mM Tris-
HCl, 5mM CaCl2, pH 7.9) and incubated with micrococcal nuclease to digest the 
chromatin. The reaction was stopped by the addition of EDTA to a final concentration of 
10mM. Soluble, digested chromatin was isolated by the addition of immunoprecipitation 
buffer (50mM HEPES/KOH, 140mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% Na-
deoxycholate) and isolated by centrifugation. The supernatant containing the soluble 
chromatin was removed and proteins were immunoprecipitated by standard methods. 
The immuno-conjugated beads were washed in these buffers (50mM HEPES/KOH, 
140mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate), (50mM 
HEPES/KOH, 500mM NaCl, 1mM EDTA, 1% Triton X-100, 0.1% Na-deoxycholate), 
(10mM Tris-HCl, 0.25 M LiCL, 0.5% NP-40, 0.5% Na-deoxycholate, 1mM EDTA), and 
(50mM Tris-HCl, 10mM EDTA). The immunoprecipitate was eluted with (50mM Tris-
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HCl, 10mM EDTA, 1% SDS), reverse crosslinked, treated with proteinase K, and the 
DNA was isolated using standard precipitation methods.  
 
Nocodazole arrest and release 
Cells were diluted into YPD media from overnight cultures and allowed to grow until a 
density of 107 cells per mL. Nocodazole was added to a final concentration of 15µg/mL 
and the cells were allowed to arrest for 2 hours. Cells were released from the G2/M 
arrest by washing twice in dH2O, resuspended into fresh YPD media, and collected at 
the indicated time points.  
 
Whole cell protein extracts preparation  
 
An equal number of logarithmically growing yeast cells were collected, pelleted and the 
supernatant removed. Cells were then resuspended in 0.3M NaOH and 1.2% Beta 
mercaptoethanol) to lyse the cells and incubated for 10 minutes at 40 C. TCA was 
added to the mixture to a final concentration of 7% to precipitate the proteins and 
incubated for 10 minutes at 40 C. The precipitated proteins were then collected by 
centrifuging at 6000 rpm for 2 minutes at 40 C. The supernatant was removed and the 
pellet was washed with 1M unbuffered Tris. The protein pellet was centrifudged for 30 
seconds at 14000 rpm and the supernatant removed. Whole cell extracts were 
resuspended in 5xSDS Sample Buffer and boiled for 5 minutes at 950 C. 
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Western Blot Analysis 
Whole cell extracts were resuspended in of 5×SDS loading buffer and heated at 95°C 
for 5 minutes. Whole cell extracts were separated on a 4–12% polyacrylamide gel, 
transferred to a nitrocellulose membrane, blocked, blotted with the indicated antibodies 
(see Table 4), washed, and in incubated with the corresponding secondary antibodies 
(Sigma A0168, A0545; 1:10,000). Lastly membranes were visualized with ECL reagent. 
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Table 1: Yeast strains generated for this study 
 
Strain	   Genotype	  
yAS1	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0  
yAS14	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 set1Δ:: kanr 
yAS15	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 set2Δ::kanr 
yAS21	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 set3Δ::kanr 
yAS17	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 set4Δ::kanr 
yAS25	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 set5Δ::kanr 
yAS26	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 set6Δ::kanr 
yAS19	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 set7Δ::kanr 
yAS203	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 bre1Δ::kanr 
yAS28	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 set1G951S 
yAS225	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 bre2-TAP::HIS  
yAS226	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 bre2-TAP::HIS set1Δ::KANMX 
yAS227	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 bre2-TAP::HIS set1G951S  
yAS93	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 swd1Δ::kanr 
yAS75	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 swd3Δ::kanr 
yAS90	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 sdc1Δ::kanr 
yAS10	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 bre2Δ::kanr 
yAS12	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 spp1Δ::kanr 
yAS92	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 shg1Δ::kanr 
yAS42	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 bub1Δ::kanr 
yAS44	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 bub3Δ::kanr 
yAS30	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 set1G951S bub1Δ::kanr 
yAS32	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 set1G951S bub3Δ::kanr 
yAS45	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 mad1Δ::kanr 
yAS46	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 mad2Δ::kanr 
yAS47	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 mad3Δ::kanr 
yAS33 MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 set1G951S mad1Δ::kanr 
yAS34	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 set1G951S mad2Δ::kanr 
yAS35	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 set1G951S mad3Δ::kanr 
yAS129	   MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 dam1K233R 
yAS153	   MATa his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 hht1K4R hht2K4R 
yAS36	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 hht1K4R hht2K4R bub1Δ::kanr 
yAS38	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 hht1K4R hht2K4R bub3Δ::kanr 
yAS39	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 hht1K4R hht2K4R mad1Δ::kanr 
	   28	  
yAS40	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 hht1K4R hht2K4R mad2Δ::kanr 
yAS41	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 hht1K4R hht2K4R mad3Δ::kanr 
yAS229	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 bre2-TAP::HIS hht1K4R hht2K4R  
yAS228	  
MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 bre2-TAP::HIS hht1K4R hht2K4R 
 set1Δ::KANMX  
yAS232	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 cdc20-127  
yAS233	   MATa	  his3Δ1 leu2Δ0 met15Δ0 ura3Δ0 cdc20-127 set1G951S  
yAS237	   MATa	  his3Δ1	  leu2Δ0	  met15Δ0	  ura3Δ0	  cdc20-­‐127	  hht1K4R	  hht2K4R	  
yAS234	   MATa	  his3Δ1	  leu2Δ0	  met15Δ0	  ura3Δ0	  PDS1-­‐18MYC	  	  
yAS235	   MATa	  his3Δ1	  leu2Δ0	  met15Δ0	  ura3Δ0	  PDS1-­‐18MYC	  set1G951S	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Table 2: Primers used in this study for generation of deletion strains 
 
Cassette:   Primer Name Primer Sequence:  
set1Δ::kanr SET1-550F-AS TGTTCAGTGAAGTATTATATAAA 
  SET1-550R-AS CACGAACATATTGTAATGATGGT 
bre2Δ::kanr BRE2-500F-AS CAGCCAATCTATCTTCCAGA 
  BRE2-500R-AS CTATTTCTCCAGATAACTACA 
spp1Δ::kanr SPP1-500F-AS GAAACATTGCCTGCAGTCTC 
  SPP1-500R-AS TTTATTACATGAGCTATCGTT 
set2Δ::kanr SET2-500F-AS AGAAGAACAATCTATCATAA 
  SET2-500R-AS GGCGCGGCTAGATGTTTTGTT 
set3Δ::kanr SET3-500F-AS GGCCTTGCGGGCCTGCTGGC 
  SET3-500R-As GATCCTAATGATGATGGCCAGT 
set4Δ::kanr SET4-500F-AS TCTTCGCTTATACCCGTCTC 
  SET4-500R-AS TGCAAATGAGTTATAAGTTGAAG 
set5Δ::kanr SET5-500F-AS GGTTTGCGAGCCTTACTATT 
  SET5-500R-AS ACAAGGTCAACAAGAACAGCA 
set6Δ::kanr SET6-500F-AS AACTACACTTCGGTTGATAA 
  SET6-500R-AS CAATGGTATCAAATTTGAATT 
set7Δ::kanr SET7-500F-AS TGAATAGATTAATTCATAGA 
  SET7-500R-AS ATATTTTCCCTGTTGAAATGAG 
bub1Δ::kanr BUB1-500F-AS AAAACATTCTCCTTTTGAGG 
  BUB1-500R-AS GCTCAATATGAAAAAATGAA 
bub3Δ::kanr BUB3-500F-AS AAGAAGTTAAGACAGTTAAA 
  BUB3-500R-AS AAGTGGGCGGCACCGAGTCT 
mad1Δ::kanr MAD1-500F-AS GTTTGGGCCACAATCTATAG 
  MAD1-500R-AS GTAACCATCCCCATCCACCT 
mad2Δ::kanr MAD2-500F-AS AATAGCATTAAATTCCGGAT 
  MAD2-500R-AS TGGTCTTTTGTCCTCGCTTT 
mad3Δ::kanr MAD3-500F-AS ACCAAAAGTTTACTTTGCCA 
  MAD3-500R-AS ATTTTACAACAGGTATTGAT 
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Table 2: Primers used in this study for genotyping deletion strains 
 
Cassette: Primer Name  Primer Sequence:  
set1Δ::kanr KAN-F-AS CCTCGACATCATCTGCCC 
  SET1-600R-AS TGACCCCATTTGTGTTAAAA 
bre2Δ::kanr KAN-F-AS CCTCGACATCATCTGCCC 
  BRE2-550R-AS GTCGAATAACAAAGAAGGTATAG 
spp1Δ::kanr KAN-F-AS CCTCGACATCATCTGCCC 
  SPP1-550R-AS ATTTCACTCCCTTGAGAATATAA 
set2Δ::kanr KAN-F-AS CCTCGACATCATCTGCCC 
  SET2-550R-AS TGCATTGGCAACAGTATTTTTTC 
set3Δ::kanr KAN-F-AS CCTCGACATCATCTGCCC 
  SET3-550R-AS TTCACCATCAGTTTGACTTTGAA 
set4Δ::kanr KAN-F-AS CCTCGACATCATCTGCCC 
  SET4-550R-AS GTCACGAAGCTGTTGCCAAATTT 
set5Δ::kanr KAN-F-AS CCTCGACATCATCTGCCC 
  SET5-550R-AS ACTACCCCTGTTACCCCAGGTGC 
set6Δ::kanr KAN-F-AS CCTCGACATCATCTGCCC 
  SET6-550R-AS GGATCCTCCCAAATTTGAGTGGA 
set7Δ::kanr KAN-F-AS CCTCGACATCATCTGCCC 
  SET7-500R-AS CAAAATAGCCGAAGGCACCAGAA 
bub1Δ::kanr KAN-F-AS CCTCGACATCATCTGCCC 
  BUB1-550R-AS TTGTCGTTATTAGAGTAGGT 
bub3Δ::kanr KAN-F-AS CCTCGACATCATCTGCCC 
  BUB3-550R-AS CCAAGGCTTTTTTGTAGTTG 
mad1Δ::kanr KAN-F-AS CCTCGACATCATCTGCCC 
  MAD1-550R-AS AACAAGCTTTTCTGCCGTAG 
mad2Δ::kanr KAN-F-AS CCTCGACATCATCTGCCC 
  MAD2-550R-AS ATTACGAGACCTACTCCAAA 
mad3Δ::kanr KAN-F-AS CCTCGACATCATCTGCCC 
  MAD3-550R-AS TGATCCTATTAGACTCCTAT 
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Table 3: Plasmids generated for this study 
 
Construct Content   
Content (Amino Acids) 
Mutations Source:  
pGEX4T1 GST   GST     
GE 
Healthcare 
pAS47 GST-Bub3-full length GST-Bub3 (1-342)   This study 
pAS28 GST-Cdc20-full length GST-Cdc20 (1-611)   This study 
pAS48 GST-Mad2-full length GST-Mad2 (1-197)   This study 
pAS119 GST-Mad2-Open GST-Mad2 (1-191)   This study 
pAS120 GST-Mad2-Closed GST-Mad2 (1-197) R126E/Q127A This study 
pAS126 GST-Cdc20-Wd40 GST-Cdc20 (289-611)   This study 
pAS128 
GST-Cdc20-Wd40-
G544R GST-Cdc20 (289-611) G544R This study 
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Chapter 3: Results 
 
Loss of SET1 induces benomyl resistance. 
Our previous studies demonstrated that Set1 has unique functions in mitosis that are 
independent of its functions in transcriptional regulation (Zhang 2005; Latham, 
2011).  To further address how lysine methylation might regulate mitosis, we subjected 
cells bearing deletions in SET1 or in other SET domain encoding genes, to growth in 
the presence of the microtubule depolymerizing agent, benomyl. Microtubule 
depolymerizing drugs interfere with mitotic spindle stability, blocking mitotic 
progression. Mutations in genes required for formation of the mitotic spindle, in 
components of the kinetochore, or in the activation and maintenance of mitotic 
checkpoints are characteristically sensitive to microtubule depolymerizing drugs.  
Using a five-fold serial dilution assay coupled with increasing amounts of benomyl, we 
discovered that set1 mutant cells are highly resistant, rather than sensitive, to high 
levels of benomyl. SET1 cells grow similarly to wild type cells on rich media or in the 
presence of DMSO vehicle alone, but they display continued growth in levels of 
benomyl that completely block growth of wild-type cells.  No other SET domain gene 
deletion resulted in a resistance phenotype, indicating a unique function for Set1 in 
responding to microtubule poisons (Figure 3). Interestingly, since SET2 encodes the 
lysine methyltransferase required for histone H3 K36 mono-, di-, and tri-methylation, 
which is also associated with active transcription, our results suggest that defective 
transcription is not sufficient to induce benomyl resistance.  
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Figure 3: The set1Δ  strain is resistant to benomyl  
A serial five-fold dilution growth assay was used to reveal a resistance to benomyl 
phenotype. Strains were placed onto either control plates (YPD) or plates containing 
30µg/mL of benomyl (BENOMYL). Plates were plated at 300 C for 2 days.  
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 Figure 3  
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To address whether the benomyl resistance phenotype caused by SET1 deletion 
reflects loss of Set1 catalytic activity, we subjected cells bearing a mutation in the Set1 
catalytic site (Nagy et al., 2002) to growth in the presence of the drug. Importantly, 
although a recent report found that many mutations in Set that affect methyltransferase 
activity result in lower amounts of total Set1 protein (Soares et al., 2014), we detect 
equal amounts of wild-type Set1 and Set1G951S protein in whole cell extracts, as 
detected by immunoblot (Figure 4).   Moreover, we find equal incorporation of wild type 
and mutant Set1 into the COMPASS complex, isolated via affinity purification of Bre2, 
another COMPASS component (Figure 5). As expected, the G951S mutation 
abrogated the ability of Set1 to methylate histone H3K4 (data not shown).   Importantly, 
cells bearing the set1G951S mutation displayed benomyl resistance equivalent to that 
caused by SET1 deletion (Figure 6), indicating Set1 catalytic activity is required for 
proper benomyl response.   
These results are consistent with a large scale screen reported previously that 
indicated BRE1 mutants display resistance to benomyl (Rieger et al., 1999). Bre1 is a 
targeting factor for the Rad6 ubiquitin ligase that is required for histone H2B K123 
mono-ubiquitination (Nakanishi et al., 2009), an upstream event required for Set1 
mediated methylation of both H3 K4 and Dam1 K233 (Latham et al., 2011; Lee et al., 
2007a).  
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Figure 4: Total Set1 protein in wild-type and set1 mutants   
Whole cell extracts from WT (SET1), set1Δ, and the set1G951S strain were prepared 
and resolved on a gel. Pgk1 was used as a loading control.  
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Figure 5: Incorporation of WT and Set1G951S proteins into COMPASS 
Wild-type Set1 and Set1G951S proteins both similarly associate with the COMPASS 
component Bre2. Immunoprecipitation (IP) assays were used to pull down Bre2 and the 
associated levels of Set1 was assessed in wild-type (WT) and set1G951S strains. 
Bre2-TAP (α-Protein A) and Pgk1 (α-Pgk1) were used as loading controls.  
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Figure 6: The bre1Δ ,  set1Δ ,  and set1G951S strains are resistant to benomyl  
A serial five-fold dilution growth assay of yeast strains with the indicated genotypes was 
performed to visualize growth phenotypes. Cells were placed onto YPD plates (YPD) or 
plates containing 30µg/mL of benomyl (BENOMYL) and incubated at 300C for 2 days.  
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Different components of the COMPASS complex appear to contribute to mono-, di-, or 
tri-methylation of Set1 substrates.  We find that deletion of genes encoding subunits 
required for all three methylation states, such as SWD1 and SWD3, also results in 
benomyl resistance (Figure 7). Deletion of BRE2 or SDC1 reduces dimethylation and 
inhibits trimethylation of H3K4, and these mutations also induce substantial resistance 
to benomyl, although not quite to the same degree as caused by SET1 
mutations.   Deletion of SPP1 eliminates trimethylation of H3K4 without affecting mono- 
and dimethylation. Interestingly, spp1 mutants display only a slight benomyl resistance, 
indicating that loss of trimethylation of COMPASS substrates is not sufficient to trigger 
resistance. Deletion of SHG1 is reported to increase di- and trimethylation of 
H3K4.  This deletion also fails to induce benomyl resistance. Together, these results 
indicate that mono- and dimethylation of substrates by Set1, working within the 
COMPASS complex, is required for proper response to microtubule poisons. 
The benomyl resistance phenotype could be a downstream affect of additional cell 
cycle defects caused by set1 mutations. Contrary to experiments previously described 
(Nislow et al., 1997), the set1Δ cells used here do not display any aberrations in cell 
cycle distribution as measured by flow cytometry (Figure 8) and a budding index assay 
(Figure 9).  Consistent with previous data (Miller et al., 2001), our set1Δ cells do grow 
at a marginally slower rate compared to wild-type cells (Figure 10), and this slow 
growth correlates with a slightly reduced count in colony forming units (Figure 10).  
Lastly, no abnormal cellular morphology phenotypes were observed (Figure 11).  
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Figure 7: COMPASS mutants are benomyl resistant 
A serial five-fold dilution growth assay of yeast strains with the indicated genotypes was 
performed to visualize growth phenotypes. Cells were placed onto YPD plates (YPD) or 
plates containing 30µg/mL of benomyl (BENOMYL) and incubated at 300 C for 2 day 
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Figure 8: Cell cycle distribution of wild-type and set1Δ  cells 
Cell cycle analysis was assessed in both wild-type (blue) and set1Δ  (red) 
asynchronous cultures. Cells were subjected to DNA labeling, flow cytometry analysis, 
and corresponding histograms were generated. Peaks associated with cells in G1 and 
G2 are labeled accordingly. 
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Figure 9: Budding index of wild-type and set1Δ  cells 
The budding index of wild-type (WT) and set1Δ cells was assessed by dividing fixed 
cells into three categories; cells with no bud, cells with a small bud, and cells with a 
large bud. These categories correspond to G1, S, and G2/M, respectively. 
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Figure 10: Growth and colony forming assays of wild-type and set1Δ  cells 
Overnight cultures were diluted into fresh media and cell growth was assessed by Optic 
Density (O.D.) over time in both wild-type (WT) and set1Δ cells (top panel). In addition, 
equal amounts of wild-type (WT) and set1Δ cell cultures were taken from these growth 
assays at the indicated time points and assessed for cell viability by counting colongy 
forming units on normal YPD plates (bottom panel).  
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Figure 11: Wild-type and set1Δ  cells display a similar cell morphology.  
Yeast strains were fixed and Differential Interface Contrast (DIC) images were taken to 
assess overall cell shape, size, and morphology,  
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Figure 11 
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Therefore, the benomyl resistance phenotype displayed by set1 mutants is unlikely to 
be a downstream affect of other cell cycle anomalies.  
Benomyl resistance of set1G951S cells requires an intact Spindle Assembly  
Checkpoint and Cdc20 inhibition.  
Resistance to benomyl and other spindle poisons could reflect a failure of cells to take 
up the drug or a failure in regulation of the Spindle Assembly Checkpoint among other 
possibilities.  To determine if activation of the SAC is required for the benomyl 
resistance of set1 mutants, we deleted genes encoding SAC components in the 
set1G951S strain. We found that deletion of BUB1 and BUB3 eliminated the resistance 
of set1G951S cells to benomyl (Figure 12). These data indicate that these SAC 
components are required for the resistance phenotype and also that the set1 mutation 
does not prevent uptake of the drug, as the double mutants displayed a sensitivity to 
benomyl similar to that of bub1 and bub3 single mutants.  Deletion of MAD1, MAD2, 
and MAD3 also suppressed the benomyl resistance phenotype of set1G951S cells 
(Figure 13). Collectively, these data indicate that the SAC must be activated and intact 
for the benomyl resistance to occur in the set1 mutant cells.  
SAC component proteins bind to and inhibit Cdc20 to block entry into anaphase upon 
disruption of microtubule-kinetochore interactions. To further define the role of SAC 
activation in the benomyl resistance phenotype, we introduced a mutation that blocks 
CDC20 inhibition into set1G951S cells. The cdc20-127 mutation is a dominant allele 
that blocks binding of Mad2 and Mad3 to Cdc20, thereby inhibiting SAC mediated cell  
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Figure 12: The SAC is required for the benomyl resistance of set1 mutants  
Serial five fold dilution assay of yeast strains with the indicated genotypes placed onto 
YPD plates (YPD) or YPD plates containing 30µg/mL of benomyl (BENOMYL). Cells 
were then incubated at 300 C for 2 days. 
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Figure 13: The SAC is required for the benomyl resistance of set1 mutants  
Serial five fold dilution assay of yeast strains with the indicated genotypes placed onto 
YPD plates (YPD) or YPD plates containing 30µg/mL of benomyl (BENOMYL). Cells 
were then incubated at 300 C for 2 days. 
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cycle arrest (Hwang et al., 1998).   We found that set1G951S cdc20-127 double 
mutants are sensitive to benomyl compared to set1G951S mutants alone, indicating 
that binding of SAC components to Cdc20 is required for the benomyl resistance 
phenotype (Figure 14).  Our data suggest loss of SET1 mediated lysine methylation 
creates a benomyl resistance phenotype that requires Cdc20 inhibition and might 
reflect an overactive SAC in the presence of the set1 mutant.  
One phenotype reported previously for a temperature sensitive mutant of Cdc20, 
cdc20-1, has a thick mitotic spindle (Sethi et al., 1991), although this phenotype 
appears to be variable. We evaluated the mitotic spindle in our set1 mutant cells using 
confocal microscopy, and we observed increase in fluorescence consistent with a 
thicker mitotic spindle in the set1G951S strain compared to wild-type cells (Figure 15). 
The mitotic spindle defect displayed by the set1G951S mutants suggests that loss of 
lysine methylation of a Set1 substrate may contribute to inhibition of Cdc20.  
To further address SAC activation and release in set1G951S cells, we monitored Pds1 
destruction by the APC. Pds1 (Securin) is a key substrate of the APC, and its 
ubiquitination and proteolysis are required for separation of sister chromatids and 
progression to anaphase.  We treated both wild-type and set1G951S cells with 
nocodazole to activate the Spindle Assembly Checkpoint.  Flow cytometry indicated 
that both wild-type and set1G951S cells arrested in G2/M, as expected. The cells were 
then released into fresh media, without drug, and mitotic progression was monitored by 
assessing Pds1 stability coupled with cell cycle analysis.  Immunoblots indicate that  
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Figure 14: Cdc20 inhibition is required for the benomyl resistance of set1 
mutants  
Serial five fold dilution growth assay of yeast strains with the indicated genotypes 
placed onto YPD plates (YPD) or YPD plates containing 30µg/mL of benomyl 
(BENOMYL). Cells were then incubated at 300 C for 2 days. 
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Figure 15: set1G951S mutants have a thicker mitotic spindle  
SET1 catalytic mutant cells (set1G951S) display a more robust mitotic spindle staining 
compared to wild-type cells (WT). Immunofluorescence confocal images of wild-type 
and set1G951S mitotic cells are shown. Tubulin (green) and DAPI (blue) were used to 
identify cells undergoing mitosis from an asynchronous culture. Mitotic cells are 
outlined in white. 
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Figure 15  
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Pds1 is degraded at a slower rate in set1 mutant cells, (Figure 16). These results 
indicate that set1 mutants arrest normally after SAC activation, but they exhibit 
prolonged inhibition of the APC after checkpoint release. 
Loss of histone H3 K4 methylation results in a benomyl resistance and mitotic 
spindle phenotype.  
Two COMPASS substrates have been identified so far in yeast, histone H3K4 (Briggs 
et al., 2001) and Dam1 K233 (Zhang et al., 2005). We created yeast cells bearing 
mutations in these methylation sites in histone H3 and Dam1 in order to determine if 
either of these COMPASS substrates plays a role in regulating cellular responses to 
mitotic poisons. We found that dam1K233R bearing cells are sensitive to benomyl, 
much like wild-type cells.  However, cells bearing mutations blocking histone H3K4 
methylation (H3K4R) display benomyl resistance to a degree very similar to that of the 
set1G951S cells (Figure 17). Importantly, we confirmed that Set1 protein levels and 
incorporation into the COMPASS complex are not affected by the H3K4R mutation 
(Figure 18).  Together these data indicate that H3K4 methylation by Set1 plays a role in 
cellular response to microtubule depolymerizing drugs.  
To determine if histone H3K4 mutants also display a more robust staining of the mitotic 
spindle as seen in the set1G951S strain, we performed immunofluorescence staining of 
polymerized tubulin in wild-type, dam1K233R, H3K4R, and set1G951S yeast (Figure 
19).  The mitotic spindle in the dam1K233R strain appeared similar to that in wild-type 
cells. In contrast, the mitotic spindle in the H3K4R strain resembled that seen in the  
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Figure 16: Pds1 degrades more slowly in set1 mutant cells  
Cell cycle arrest and release experiments reveal that Pds1 is more stable in set1 
mutants (set1G951S) than in wild-type cells (WT). Cells were arrested in G2/M using 
nocodazole and released into fresh media. Samples were taken at the indicated time 
points, whole cell extracts and immunoblots were prepared and probed with α-Myc 
antibody to assess the protein levels of Myc-Pds1. Western blots for Pgk1 served as a 
loading control. Cells from the indicated time points were taken for analysis using flow 
cytometry. Histograms of DNA content reveal the cell cycle profile of the indicated 
strains at specific times after cell cycle arrest and release.  
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Figure 17: H3K4R mutants are benomyl resistant 
Serial five fold dilution growth assay of wild-type (WT) and mutants with the indicated 
genotype placed onto either control plates (YPD) or plates containing 30µg/mL of 
benomyl (BENOMYL). Cells  were incubated at 300 C for 2 days. 
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Figure 18: Incorporation of Set1 proteins into COMPASS in wild-type and mutant 
cells 
Set1 proteins similarly associate with the COMPASS component Bre2 in SET1, 
set1G951S, and H3K4R mutant cells. Immunoprecipitation (IP) assays were used to 
pull down Bre2 and the associated levels of Set1 protein was assessed using α-Set1. 
Bre2-TAP (α-Protein A) and Pgk1 (α-Pgk1) were used as loading controls.  
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Figure 18 
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Figure 19: H3K4R mutants have a thick mitotic spindle 
Immunofluorescent images of wild-type (WT) and mutants with the indicated genotype. 
Images of mitotic cells were taken on a confocal microscope. Tubulin (green) and DAPI 
(blue) were used to identify cells undergoing mitosis from an asynchronous  
culture. Mitotic cells are outlined in white. 
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Figure 20: The SAC is required for the benomyl resistance of H3K4R mutants 
Serial five fold dilution growth assay of wild-type (WT) and mutants with the indicated 
genotype placed onto either control plates (YPD) or plates containing 30µg/mL of 
benomyl (BENOMYL). Cells were incubated at 300 C for 2 days. 
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Figure 21: The SAC is required for the benomyl resistance of H3K4R mutants 
Serial five fold dilution assay of wild-type (WT) and mutants with the indicated genotype 
placed onto either control plates (YPD) or plates containing 30µg/mL of benomyl 
(BENOMYL). Cells were incubated at 300 C for 2 days. 
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Figure 22: Loss of SAC components has no effect on H3K4 methylation 
Whole cell extracts taken from wild-type (WT), set1Δ, and mad2Δ cells to compare di- 
and tri-methylation of histone H3 with immunoblots. Total H3 was used as a loading 
control. 
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Figure 22 
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set1G951S cells, displaying a more robust staining of polymerized tubulin, or a “thick” 
mitotic spindle phenotype, relative to wild type cells. These data indicate that 
methylation of histone H3K4 plays a novel role in regulating the response to 
microtubule depolymerizing drugs, possibly related to increased amounts of 
polymerized tubulin or increased stability of the mitotic spindle.  
To confirm that the benomyl resistance phenotype displayed by the H3K4R mutant 
requires an intact Spindle Assembly Checkpoint (SAC), as seen in set1G951S cells, we 
created yeast bearing both the histone H3K4R mutation and mutations in SAC 
components. Like the set1G951S strain, deletion of SAC component genes suppresses 
the benomyl resistance phenotype caused by the H3K4R mutation (Figure 20 and 21). 
Immunoblots confirm that loss of SAC components such as Mad2 has no effect on 
H3K4 methylation events, as H3K4 di- and trimethylation was unaltered in mad2Δ cells 
compared to wild-type cells (Figure 22). Immunofluorescence staining of the mitotic 
spindle in wild-type, H3K4R, mad2Δ, and H3K4R/mad2Δ cells indicates that eliminating 
SAC function through deletion of MAD2 in H3K4R cells also results in loss of the thick 
mitotic spindle phenotype seen in H3K4R mutant cells (Figure 23). These data further 
link the mitotic spindle phenotype with the benomyl resistance observed in the H3K4R 
mutant cells, and indicate that loss of H3K4 methylation is affecting the SAC. To test 
whether the H3K4R mutant also regulates the SAC through Cdc20 inhibition, we 
introduced the cdc20-127 mutation into the H3K4R strain. Like the set1G951S strain, 
the H3K4R strain requires Cdc20 inhibition for benomyl resistance (Figure 24) 
supporting the model of an overactive SAC when H3K4 methylation is inhibited.   
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Figure 23: The thick mitotic spindle of H3K4R mutants requires the SAC 
Immunofluorescent images of wild-type (WT) and mutants with the indicated genotype. 
Images of mitotic cells were taken on a confocal microscope. Tubulin (green) and DAPI 
(blue) were used to identify cells undergoing mitosis from an asynchronous  
culture. Mitotic cells are outlined in white. 
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Figure 23 
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Figure 24: Cdc20 inhibition is required for the benomyl resistance of H3K4R 
mutants  
Serial five fold dilution growth assay of wild-type (WT) and mutants with the indicated 
genotype placed onto either control plates (YPD) or plates containing 30µg/mL of 
benomyl (BENOMYL). Cells were incubated at 300 C for 2 days. 
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SAC components and Cdc20 bind directly to histone H3.  
Methylation of H3K4 can directly affect binding of other proteins to chromatin, and 
several H3K4me reader domains have been identified, including WD40 repeats 
(Wysocka et al, 2005). Interestingly, both BUB3 and CDC20 contain multiple WD40 
repeats. In addition, Mad2 contains a HORMA domain, which is found in multiple 
chromatin-associated proteins (Figure 25) (Aravind and Koonin, 1998; Muniyappa et 
al., 2014). To test whether any components of the SAC or Cdc20 bind directly to 
histones, we performed GST pull down experiments using recombinant, N-terminally 
tagged GST fusion proteins expressed in E. coli together with total calf thymus 
histones. We have found that GST-Bub3, GST-Cdc20, and GST-Mad2 all directly bind 
histone H3 but not H2A and H2B (Figure 26).  
 
The WD40 repeats in Cdc20 are located in the C-terminal portion of the protein. To 
verify that these repeats are sufficient for direct binding of Cdc20 to histone H3, we 
expressed and purified a construct lacking the N-terminal portion of the protein. In 
addition, we expressed a version of GST-WD40 fusion protein that contains the G544R 
mutation encoded in the cdc20-1 allele that exhibits limited functions in vivo (Sethi et 
al., 1991). The WD40 repeats in Cdc20 recruit substrates to the APC by binding to KEN 
and D-box motifs within the substrates (Chao et al., 2012; Tian et al., 2012).  Here we 
show that the Cdc20 WD40 repeats also directly bind to histone H3, but not to H2A and 
H2B, and that the G544R mutation abolishes H3 binding (Figure 27).    
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Figure 25: An illustration of the domains present in Bub3, Cdc20, and Mad2 
Bub3 and Cdc20 contain multiple WD40 domain repeats while Mad2 contains a 
HORMA domain.  
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Figure 26: Bub3, Cdc20, and Mad2 all directly bind histone H3  
Colloidal staining of purified recombinant proteins. Pull down assays of GST-Bub3, 
GST-Cdc20, and GST-Mad2 to identify direct binding with histones isolated from calf 
thymus. Direct binding was assayed using immunoblots of membranes probed with 
antibodies against H2A, H2B or H3. 
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Figure 27: The WD40 repeats of Cdc20 are sufficient to bind H3. 
Colloidal staining of purified recombinant proteins. Pull down assays of the WD40 
domain of Cdc20 (GST-WD40) and with a point mutant (GST-WD40-G544R) to identify 
direct binding with histones isolated from calf thymus. Direct binding was assayed 
using immunoblots of membranes probed with antibodies against H2A, H2B or H3.   
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Figure 28: Cdc20 can bind all H3K4 methylation states 
Pull down assay with recombinant GST fusion proteins and unmodified H3 (K4 me0) or 
MLA full length histones generated to mimic H3K4 monomethylation (K4 me1), H3K4 
dimethylation (K4 me2) or H3K4 trimethylation (K4 me3).  Direct binding was assayed 
using immunoblots of membranes probed with an antibody recognizing histone H3. 
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Figure 29: Bub3 can bind all H3K4 methylation states 
Pull down assay with recombinant GST fusion proteins and unmodified H3 (K4 me0) or 
MLA full length histones generated to mimic H3K4 monomethylation (K4 me1), H3K4 
dimethylation (K4 me2) or H3K4 trimethylation (K4 me3).  Direct binding was assayed 
using immunoblots of membranes probed with an antibody recognizing histone H3. 
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To address whether binding of Cdc20 or Bub3 to H3 is affected by K4 methylation, we 
repeated the GST pull down experiments using H3 bearing specific methylation states 
created by (MLA) modifications. Both GST-Cdc20 and GST-Bub3 interacted with 
histone H3 regardless of the methylation status of K4 (Figure 28 and 29).  
Mad2 can adopt two conformational forms, Open Mad2 (O-Mad2) and Closed Mad2 
(C-Mad2), in both yeast and humans (Luo et al., 2000; Nezi et al., 2006; Sironi et al., 
2002). Specific mutations can structurally constrain Mad2 to either the O-Mad2 or the 
C-Mad2 conformation (De Antoni et al., 2005; Nezi et al., 2006).  To determine whether 
Mad2 conformation affects binding to histone H3, we created GST versions of the O-
Mad2 and C-Mad2 proteins and compared binding of these conformational states to 
that of wild-type Mad2. O-Mad2 interacted less well with histone H3 relative to wild-type 
Mad2.  In contrast, C-Mad2 pulled down more histone H3 than did either the wild-type 
or O-Mad2 conformations.  None of the Mad2 proteins bound to histone H2A or H2B, 
confirming specificity for H3 interactions (Figure 30).  
In contrast to the inability of Bub3 or Cdc20 to discriminate between different 
methylation states of H3, O-Mad2 and C-Mad2 displayed strikingly different binding 
profiles to modified and unmodified forms of H3. C-Mad2 clearly bound to all 
methylation states of histone H3, whereas O-Mad2 bound best to H3K4me0 and 
displayed limited interaction with H3K4me1 (Figure 31).  These findings identify Mad2 
as a novel histone binding protein with conformation sensitive lysine methyl “reader” 
capability.  
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Figure 30: C-Mad2 directly binds H3 
Colloidal staining of purified recombinant proteins. Pull down assays of the WD40 
domain of Cdc20 (GST-WD40) and with a point mutant (GST-WD40-G544R) to identify 
direct binding with histones isolated from calf thymus. Direct binding was assayed 
using immunoblots of membranes probed with antibodies against H2A, H2B or H3.   
	   96	  
 
 Figure 30 
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Figure 31: O-Mad2 binding is inhibited by H3K4 di- and tri-methylation  
Pull down assay with recombinant GST fusion proteins and unmodified H3 (K4 me0) or 
MLA full length histones generated to mimic H3K4 monomethylation (K4 me1), H3K4 
dimethylation (K4 me2) or H3K4 trimethylation (K4 me3).  Direct binding was assayed 
using immunoblots of membranes probed with an antibody recognizing histone H3. 
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Chapter 4: Discussion 
In this study we report Set1 is required to properly silence the SAC through H3K4 
methylation, which in turn limits a novel histone H3-Mad2 protein interaction. To come 
to this conclusion, we identified a unique benomyl resistance phenotype displayed by a 
number of mutants limiting H3K4 methylation. Previous research identified that the 
SAC pathway is engaged in response to microtubule poisons, therefore we wanted to 
test if H3K4R mutants affect the SAC pathway resulting in a benomyl resistance 
phenotype. To do this, we generated multiple mutations abolishing the SAC and these 
assays revealed loss of H3K4 methylation results in an overactive SAC, which is 
functioning through Cdc20 inhibition.  
 
A major function of H3K4 methylation is to recruit or exclude protein-protein 
interactions. Our initial results indicate that loss of H3K4 methylation is affecting SAC 
function. Therefore we wanted to test if any SAC components have the ability to bind 
directly to histone H3. Interestingly, we found Bub3, Cdc20, and Mad2 directly bind to 
histone H3. To investigate if Mad2 could bind to methylated H3K4 we introduced 
mutations to create two differing conformations of Mad2, termed O-Mad2 and C-Mad2. 
We tested the binding ability of both conformations to histones modified on H3K4 and 
found that H3K4 methylation blocked the binding of O-Mad2 but bound C-Mad2, 
indicating a conformational change has the ability to facilitate H3-protein interactions 
and this is mediated through H3K4 lysine methylation. These data suggest H3 and 
H3K4 methylation facilitate the SAC by promoting or excluding protein-protein 
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interactions of differing Mad2 conformations. Importantly, we also identified the 
HORMA domain as a novel histone binding motif and Mad2 as a histone H3K4 methyl 
reader regulated by a change in conformation. These data point to a previously 
unknown mechanism for mitotic checkpoint regulation through PTMs made to histone 
H3 coupled with a conformational change to Mad2.  
 
We have shown C-Mad2 specifically bound di-methylated and tri-methylated histone 
H3K4 while the O-Mad2 could not. The mechanism by which C-Mad2 and O-Mad2 
function as a reader of differing histone H3K4 methylation states needs further 
investigation. Other regulators of the SAC have been identified that directly interact with 
C-Mad2 but not O-Mad2. H3K4 methylation could function by specifically binding to C-
Mad2 thereby blocking the dimerization of O-Mad2 and C-Mad2, an important 
regulatory event in SAC activation and maintenance (Habu et al., 2002; Mapelli et al., 
2006; Xia et al., 2004). Histone H3K4 di- and tri-methylation could function as a 
conformation specific binder of C-Mad2 which would function to exclude O-Mad2. Lack 
of histone H3K4 methylation could result in uninhibited C-Mad2 and an increased 
suppression of Cdc20 function (Figure 32).  
 
We have in vitro experiments showing histone H3K4 methylation regulates Mad2-H3 
protein interactions and we have in vivo data suggesting H3K4 methylation limits the 
SAC pathway. Previous studies have identified another silencing factor of the SAC 
named P31comet, which shares many similarities with methylated histone H3K4. P31comet  
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Figure 32: A model of APC inhibition by Mad2 in wild-type and mutant cells 
An illustration of the SAC in both wild-type (WT) and set1 mutant cells (Set1 Mutant).  
In wild-type cells, dimethylation of H3K4 (H3K4me2) specifically binds Closed Mad2 (C-
Mad2) which inhibits the interaction of Open Mad2 (O-Mad2) with C-Mad2 a regulatory 
step required for continued inhibition of the SAC. After SAC activation, H3K4me2 acts 
as a limiting factor by binding C-Mad2. In wild-type cells, the APC bound by Cdc20 is 
then able to ubiquitinate substrates such as Pds1 (Securin). In the H3K4R mutants, O-
Mad2 is not inhibited by dimethylation of H3K4 and can associate with C-Mad2 leading 
to continued inhibition of the SAC and Pds1 stability after tension is established.   
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was first identified with a yeast two-hybrid experiment in which human Mad2 was used 
as bait suggesting a direct P31comet -Mad2 interaction, much like our findings with Mad2 
and H3. Subsequent experiments indicated that overexpressing P31comet while the SAC 
was active resulted in cells that continue through the cell cycle adopting an aneuploid 
phenotype. Next, cells depleted of P31comet were arrested by activating the SAC and 
released into fresh media, cells lacking P31comet maintained an increased number of 
cells that remained in metaphase compared to control cells. These data suggest 
overexpressing P31comet silences the SAC while restricting P31comet creates cells 
deficient in SAC deactivation. We performed similar in vivo experiments and much like 
P31comet, cells lacking H3K4 methylation activated the SAC but did not properly release 
through the cell cycle suggesting a deficiency in silencing the SAC. Later studies found 
that P31comet directly binds C-Mad2 but not O-Mad2, which is similar to what we 
discovered, in our studies methylated H3K4 bound C-Mad2 but not O-Mad2. In 
addition, previous research also found P31comet bound C-Mad2 but did not interfere with 
the C-Mad2-Cdc20 interaction suggesting the relationship between P31comet, C-Mad2, 
and Cdc20 was not mutually exclusive (Xia et al., 2004). Lastly, the crystal structure of 
p31comet was resolved while associated with C-Mad2. This structure confirmed previous 
findings in which, p31comet bound to Mad2 at a site away from the Cdc20 binding site. 
Lastly, this binding interface normally associates with Mad3 and also promotes the 
interaction between O-Mad2 and C-Mad2. Therefore the association of p31comet with C-
Mad2 would result in excluding Mad3 and O-Mad2 from association with the mitotic 
checkpoint complex (MCC) and antagonize the SAC (Chao et al., 2012).  
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Our studies identified the HORMA domain encoded by MAD2 is a novel histone-binding 
motif with lysine methylation reading abilities. This creates the possibility that other 
HORMA domain containing proteins have the ability to read methylated histone marks. 
A number of other chromatin-associated proteins contain conserved HORMA domains 
in yeast and humans. These include human REV7, HORMAD1, HORMAD2, p31comet, 
and MAD2. In addition, the yeast homologs containing HORMA domains are Rev7, 
Hop1, and Mad2. 
 
Yeast and human REV7 are involved in DNA translesion synthesis and double strand 
break repair (Kolas and Durocher, 2006; Prakash et al., 2005). In addition, hREV7 is 
reported to bind and inhibit Cdh1, an ortholog of Cdc20, much like Mad2 (Listovsky and 
Sale, 2013). Although this interaction has not been reported in yeast, Cdh1 is also an 
activator of the APC through recruitment of substrates for ubiquitination and protein 
degradation. Like yeast and hMad2, hREV7 has been reported to undergo a 
conformational change upon binding to hREV1 (Hara et al., 2010). hREV7 has also 
been implicated in cancer. Triple negative breast cancer frequently loses hREV7 
expression and this loss of hREV7 results in PARP inhibitor resistance (Xu et al., 
2015).  
 
Yeast Hop1 is a meiosis specific protein that is related to human meiosis proteins 
HORMAD1 and HORMAD2, which are paralogs. HORMAD proteins and histone H3K4 
trimethylation have both been implicated in meiotic recombination (Handel and 
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Schimenti, 2010) although never molecularly connected. In addition, recent research 
found C. elegans Hop1 homologs could undergo a conformational change much like 
MAD2 and REV7 and identified conserved homologous sequences in HORMAD1 and 
HORMAD2 implicating a possibility for conformational change of all human HORMA 
domain-containing proteins (Kim et al., 2014). Lastly, in triple negative breast cancers, 
HORMAD1 overexpression has been implicated in deficient homologous recombination 
(Watkins et al., 2015). Due to the striking similarities between HORMA domain 
containing proteins, their association with chromatin, and their implications in human 
disease we propose an extensive study to characterize their association with histone 
H3. Further investigation is required to identify if HORMA domain containing proteins 
also specifically bind histone H3 in humans and in yeast, if a conformational change 
affects the binding, and if these interactions are either promoted or excluded by H3K4 
methylation events.  
 
Our data identifies a novel pathway showing how mutations to lysine 
methyltransferases and SAC components in yeast might contribute to cancer 
progression through loss of intricacies in mitotic checkpoint regulation in humans. The 
human homolog of yeast SET1 is MLL1. MLL1 is mutated in a subset of aggressive 
acute lymphoblastic leukemias (Guenther et al., 2005; Zeleznik-Le et al., 1994) 
possibly through misregulation of histone H3K4 methylation. We also reported yeast 
BRE1 as being required for both H3K4 methylation events and a proper response to 
the microtubule poison, benomyl. Human BRE1 displays tumor suppressor features 
	   106	  
(Shema et al., 2008) associated with lack of H2B ubiquitination and hBRE1 is 
frequently down regulated in metastatic prostate cancers (Varambally et al., 2005). It is 
important that future work identifies if proper SAC function is lost in cancers maintaining 
mutations either to MLL1 or BRE1.  
 
Interestingly, SAC components are often mutated or misregulated in cancer. Bub1 
dominant negative mutations display a chromosomal instability (CIN) phenotype in 
colorectal cancer cell lines (Cahill et al., 1998) and mutations have been identified in 
many other cancer types (reviewed in (Fang and Zhang, 2011)). Additionally, although 
not directly mutated, the SAC pathway is repetitively attenuated by activators and 
repressors. For example, an increase in Mad2 is seen following Rb and p53 inhibition 
and reduction of Mad2 in these studies rescues the CIN observed in Rb and p53 
deficient mice (Schvartzman et al., 2011).  Lastly, Cdc20 is also overexpressed in a 
high percentage of colorectal and bladder cancer tissues and Cdc20 expression is 
repressed upon introduction of wild-type p53 expression (Kidokoro et al., 2008). These 
two studies link p53 inhibition to an aberrant SAC. p53 is mutated or deleted in over 
50% of human tumors (Hollstein et al., 1991) suggesting an attenuated SAC pathway 
could play a substantial role in cancer initiation, maintenance, or progression.  
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Future Directions 
Our findings indicate that Set1 negatively regulates the SAC through binding of histone 
H3 with Mad2. We additionally found Bub3 and Cdc20 also interact with H3 but in a 
manner independent of H3K4 methylation. Bub3 and Cdc20 can bind unmodified, 
mono-, di-, and tri-methylated histone H3K4. Although we identified these two proteins 
as novel histone H3 interacting proteins, we did not elucidate how the Bub3-H3 and 
Cdc20-H3 interactions are regulated or their function. It is likely that alternative histone 
H3 modifications either promote or inhibit the binding of Bub3 and Cdc20 to chromatin. 
By using our in vitro binding assays, we could identify histone marks excluding or 
promoting the binding of Bub3 and Cdc20 to H3. Further studies of the effect histone 
H3 has on the SAC pathway through Bub3 and Cdc20 would uncover additional 
regulatory events and implicate alternative PTMs in SAC regulation. 
 
Another worthwhile experiment is to identify if hMAD2 can also bind histone H3 while it 
is in a closed conformation. We know histone H3K4 methylation is conserved between 
yeast and humans although we have not asked if hMAD2 maintains the ability to act as 
a lysine methyl reader. Mutations can be added into the hMAD2 sequence to lock 
MAD2 into either an O-MAD2 or a C-MAD2 conformation. Much like the studies we 
performed here, these H3-MAD2 interactions can be evaluated by using recombinant 
MAD2 and histone H3 to limit other PTMs. Similarly to the studies describing the 
p31comet –H3 interaction, we should also use protein crystallization to resolve the H3 C-
Mad2 protein-protein interface. Identifying the binding surface of Mad2 with modified 
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H3 would facilitate in our understanding of SAC regulation. In addition, resolution of the 
C-Mad2 binding pocket that identifies and binds methylated H3 and how it changes 
when Mad2 is in an open conformation is crucial to our understanding of histone methyl 
readers and how Mad2 limits interactions with methylated binding partners due to a 
conformational change.   
 
Histone H3K4 methylation is one of three H3 lysine methylation events in yeast. In 
addition, other lysine methylation events on histone H3 might serve to either promote or 
inhibit HORMA domain-histone H3 interactions. These include H3K36 and H3K79 
mono-, di-, and tri-methylation. These interactions between H3 methylated at either 
K36 or K79 could easily be tested with our in vitro histone binding assays coupled with 
recombinant Bub3, Cdc20, and Mad2. Lastly, additional well-studied post-translational 
modifications of histone H3 such as H3S10 phosphorylation or H3K9 and K14 
acetylation should also be introduced into our binding assays. Other histone 
modifications might also play a role in either promoting or inhibiting histone H3 
interactions with Bub3, Cdc20, or Mad2. Further analysis of how histones interact with 
SAC components and Cdc20 is required to identify novel regulatory mechanisms 
identifying how SAC components directly bind to histone H3 and the downstream 
functions of these interactions.  
 
Lastly, it would be informative to describe SAC-H3 interactions in time and space. SAC 
proteins have the ability to change their subcellular localization and associate with 
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multiple cellular structures including the nuclear envelope, both attached and 
unattached kinetochores, and the mitotic spindle. In addition, cell cycle changes and 
SAC activation have the ability to change SAC protein interactions. Identifying exactly 
when and where SAC proteins bind chromatin will be informative in understanding both 
chromatin and SAC regulatory events. Understanding if regulation is at the telomeres, 
centromeres, specific to certain genes, or dispersed throughout the genome will further 
identify how the genome is regulated throughout the cell cycle.  
 
Significance 
Here we show the first evidence of H3K4 methylation silencing the Spindle Assembly 
Checkpoint through direct interactions with C-Mad2. By using yeast as a model system 
combined with point mutations directly abolishing histone H3K4 methylation we were 
able to exclusively link loss of H3K4 methylation with a novel benomyl resistance 
phenotype.  Through additional mutations introduce into the H3K4R mutant background 
we were able to further conclude loss of H3K4 methylation results in an overactive SAC 
that functions through Cdc20 inhibition. We then performed in vitro recombinant binding 
assays with MLA histones to extensively study how H3K4 methylation affects direct 
binding of Bub3, Cdc20, and Mad2 to histone H3. These binding studies identified 
novel H3 interacting proteins and a novel histone H3-binding motif, the HORMA 
domain. Lastly, a conformational change to C-Mad2 promotes Mad2-H3K4 methyl 
interactions, while the O-Mad2 conformation abolishes interactions with methylated 
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H3K4. These data suggest for the first time, a conformational change to the Mad2 
protein produces a novel lysine methyl reader.  
 
Our data links the SAC with histone H3K4 methylation thus uncovering a hidden 
regulatory event required for proper cell division. Histone H3K4 methylation and the 
SAC are highly conserved and attenuation of either histone modifications or the SAC is 
associated with cancer. A further understanding of how H3K4 methylation and SAC 
inhibition contribute to cellular regulatory events will help us to better understand 
cancer progression and human disease. Lastly, our approach using yeast genetics and 
cell biology assays coupled with in vitro binding assays led to a conclusive approach to 
find novel SAC activators and inhibitors, suggesting further experiments will identify 
additional regulators of cell division through post translational modifications and 
possibly histone H3.  
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